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Objectives: Schizophrenia is responsible for a significant proportion of burden of mental diseases in Iran. 
Lack of a follow-up system has resulted in the repeated hospitalizations. In this study it is hypothesized 
that standardized living skills training delivered to participants with schizophrenia in outpatient and 
inpatient centers can be effective compared to a control group (with occupational therapy) in reducing 
psychopathology severity and increasing quality of life. 
Methods: This is a multi-centered parallel group randomized controlled trial in Iran and it is single-
blinded. Eligible participants are randomly allocated into two groups in a 1:1 ratio. Participants are 
assigned by stratified balanced block randomization method. The trial is conducted in the cities of Tehran 
and Mashhad. Its aim is to recruit 160 clients with schizophrenia. The intervention for the experimental 
group is social living skills training. The intervention for the control group is occupational therapy. The 
intervention for both groups is conducted in 90 to 120-minute group sessions. The primary outcome of 
the study would be a decrease in psychopathology severity, an improvement in participants' quality of 
life, and reduction in family burden will be followed for 6 months. 
Discussion: This paper presents a protocol for a randomized controlled trial of independent and social 
living skills training intervention delivered to participants with schizophrenia. If this intervention is 
effective, it could be scaled up to be developing for policymaking and improving outcomes for 
schizophrenic participants and their families in Iran. 
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Introduction  
Schizophrenia is a severe mental disorder that 
usually onsets in early adulthood and is often 
associated with persistent or relapsing symptoms 
and a range of adverse outcomes (1,2). Impairments 
in social functioning are among the most debilitating 
and treatment refractory aspects of schizophrenia 
(3). A survey in Iran showed that the lifetime 
prevalence of psychotic disorders in Iran is 1%  (4). 
It is estimated that there are at least 400,000 
participants suffering from schizophrenia in Iran (5). 
In low-income countries the availability of 
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community services is the exception not a norm (6). 
Thus, for the majority of clients with schizophrenia 
and their families there is little access to any 
psychological care (7). In the past five decades, 
mental health services have seen major strategic 
changes (8,9). Mental health services in developing 
countries have improved but they are not efficient, 
not well designed and public-private centers are 
inadequate and insufficient (10). In Iran services are 
limited to psychiatric hospitals and private offices. 
Revolving door phenomenon generally is occurring 
(11).Providing psychosocial services can have a 
significant impact on decreasing relapse and 
improving participants' clinical condition (12). It can 
also reduce burden of psychiatric disorders and 
increase the efficacy of interventions (13). During 
1960s and 1970s the effectiveness of social skills 
training has been studied and emphasized (14).In 
several studies, participants' families have reported 
their major needs to be gaining knowledge and 
learning necessary skills to cope with this mental issue 
of their family members (15,16). Many studies have 
shown that family intervention with the aim of 
connecting with participants' family and educating and 
supporting them are effective in decreasing the rate of 
relapse, hospital stay period and family burden (17). 
Family intervention can also improve participants' 
functioning (18). Various clinical guidelines have 
suggested family intervention as the main part of 
treatment for serious mental disorders (19). 
Social skills training along with group therapy can 
improve patient's functioning and quality of 
interpersonal interactions (20). Study of the effects 
of social skills training has showed an increased 
ability in performing daily life activities and 
improving the negative signs of schizophrenia (21). 
Thus scaling up an accessible, acceptable and 
effective structured and feasible services for clients 
with schizophrenia is an urgent mental healthcare 
system (22). Promising results need to be rigorously 
tested through a randomized controlled trial. The 
objectives of the trial are to see whether clinical skill 
training will be effective in improving a range of 
outcomes in participants with schizophrenia and 
their families in a 6 months follow-up and to 
determine if the skill training intervention is 
applicable in Iran. The primary objectives of the trial 
are to determine whether the social and independent 
and social living skills training (SISLST)1 will be 
effective in participants with schizophrenia, i.e. 
                                                 
1. Designed by Dr. Robert Paul Liberman 
reducing psychopathology severity, and improving 
global functioning. The secondary objectives are to 
determine whether SISLST will be effective in 
improving adherence to antipsychotic treatment and 
service satisfaction. The objectives for schizophrenic 
participants' families are to determine whether 
SISLST will be effective in improving quality of life 
and reducing family burden. 
 
Methods 
This is a randomized controlled trial with equal 
allocation of participants between parallel groups. 
The study (allocation ratio is 1:1) will compare two 
groups of people with schizophrenia allocated to 
receive either (I) SISLST or (II) occupational 
therapy with 6 months follow up. The participants 
are schizophrenic participants in the age range of 18 
to 55 years old, literate, are in the active phase of 
illness and have a diagnosis of schizophrenia as per 
diagnosed schizophrenia diagnostic and statistical 
manual of mental disorders, 4th Edition, Text 
Revision criteria (DSM-IV-TR) (23). They have 
been hospitalized at least once before and have an 
overall moderate severity of the illness based on the 
global assessment of functioning (GAF) (40-70) 
scale (24).  All participants are living with a family 
member. Also, the participants do not suffer from 
clinically significant physical or neurological 
disorders/mental retardation and drug dependence or 
abuse. If there is risk that a participant might harm 
himself/herself and others, s/he will be excluded 
from the study. Participants are recruitment from 
within the existing cases at each center.  
The trial will be conducted in two centers in Iran: a 
university-affiliated hospital in Tehran and in social 
welfare-affiliated center (aka BEHZISTY) in 
Mashhad. Both centers have been chosen to reflect a 
diversity of health system contexts. Interventions 
will be conducted 3 times per week at outpatient 
centers and 5 times per week at inpatient centers for 
a period of 90 to 120 minutes per session. Each 
session is conducted in a group with 4 to 6 
participants. In the maintenance phase during 
months 6, the therapists will monitor the progress 
and discuss strategies to deal with the emerging 
issues. Almost all clients with schizophrenia in the 
studied centers should have psychotropic 
medication. The SISLST includes the following 
components: medication and symptom management, 
leisure management and basic conversational skills. 
Each module teaches from 4 to 9 skills and each 
skill is taught with "learning activities". All 
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information has been systematically translated into 
the Farsi for the use of participants and families. The 
intervention has been systematically piloted at 
inpatient and outpatient centers. Based on the results 
of the field-testing (content analysis), the final 
version has been adapted. 
Also family members of the intervention group will 
participate, as generalization agents, in separate 
sessions (one weekly two-hour 4 family group 
sessions) where they will be provided structured 
educational information concerning learned skills as 
well as problem solving and home assignment. The 
occupational therapy (control) group will receive 
psychosocial occupational therapy services 
including group therapy (group discussion), leisure 
activities, arts and structured activities. This group 
will receive the same assessments as the intervention 
group. They will receive traditional occupational 
therapy. The prescribed occupations are health-
related activities (personal health, medication 
monitoring, daily activity monitoring, living skills 
training, physical activities, art groups, recreation 
activities, social groups). In the inpatient setting 
(Iran psychiatric hospital in Tehran) a psychologist 
will screen participants after the active phase in 
wards one time a week for eligibility criteria. In 
outpatient setting, two psychologists will choose the 
participants. The screeners will provide a brief 
overview of the trial through a group meeting and 
ask the person and the caregiver(s) whether they 
want to participate in the trial or not. All clients with 
schizophrenia will be assigned a unique ID. For 
those who have refused, the screener has the option 
of motivating their participation during the course of 
the recruitment period. Trial consent procedures 
have been designed in a non-technical language to 
reduce the cognitive problems (25). Participants will 
be informed with verbal and written information 
regarding the study in a (individual and group) 
meeting. If they refuse to participate, the screener 
will record their reasons. The participants will be 
supervised and reported in compliance with the 
recent CONSORT recommendations (26). Eligible 
participants are then assigned randomly to 
intervention or control groups by stratified balanced 
block randomization method with allocation 
concealment (allocation ratio 1:1). The allocation list 
has been generated independently by a statistician 
and diffused to the researcher before the beginning 
of the recruitment for the trial. The researcher will 
be responsible for assigning the unique trial ID for 
each participant in the trial and will notify the center 
coordinator. The nature of such services prevents 
adequate blinding of participants and the raters in 
follow-up evaluations process. To maintain blinding 
of these assessments, researchers are independent of 
the assessors. 
Outcome measurements- We will use the 
assessments, at baseline, after the end of 
intervention, and 6 months follow up. For the 
symptoms of schizophrenia the primary outcome 
assessments will be recorded with the positive and 
negative symptoms scale (PANSS) (27). Also, world 
health organization quality of life (WHOQOL)-
BREF will be used for measuring quality of life 
(28). For measuring the secondary outcomes for 
clients with schizophrenia, we will measure 
participants' satisfaction with the services by the 
client satisfaction questionnaire (CSQ)-8 (29). For 
measuring global functioning, we will use the GAF. 
The family burden will be assessed by the 
Experience of Caregiving Inventory (ECI) (30). 
Data collection- Data are collected from all 
participants at time of index admission, discharge 
and at 6-month follow-up. Raters are clinical 
psychologists who are trained in a 2-day workshop 
on how to use data collection tools before the 
initiation of the study. Inter-rater reliability of 
ratings is also examined. Raters are not chosen from 
care providers to minimize bias. Studies show that 
the rate of "loss to follow up" for ratings in these 
setting is high (31).  
Quality assurance and fidelity management- The 
same supervision procedure and protocol is 
employed for the whole process of case recruitment 
and data collection. To ensure fidelity, the 
intervention process indicators will be checked for 
significant divergence from pre-protocol norms 
related to the delivery of the intervention. In 
addition, randomly some of the sessions at each 
center will be assessed by a key researcher. To 
ensure quality assurance, all assessors have equal 3-
sessions trainings with a single team and single 
training module and guidelines in both centers to 
ensure adequate inter-rater reliability. 
Statistical analysis- SPSS version 19 will be used for 
data analysis. The findings will be displayed as 
frequencies, percentages, means and standard 
deviations, using tables and plots. Chi-squared 
analysis will be used to explore associations in the 
data. We will use the logistic regression analysis for 
the dichotomous outcome, and linear regression 
analyses for all other outcomes. The study data will 
be examined using t-tests, analysis of covariance, 
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and repeated measures of analysis of variance 
(ANOVA). An "intention to treat" approach will be 
employed based on the data from the earlier non-
randomized study (32). Sample size calculation is 
based on the PANSS as the primary outcome 
measure. The following formula is used for the 
calculation: N=2[z(1-α/2)+z(1-β)]2x(SD2)/d2. 
Sample size is estimated 4O per group; assuming 
about 30% losses to follow-up (total: 160). 
Ethical considerations- Before the conduct of the 
study, participants and their family members are 
thoroughly informed regarding the services. Written 
informed consent (non-technical language) is then 
obtained from the participants in compliance with 
the good clinical practice (GCP) guidelines (33). 
There is no penalty for not participating in the 
program. Participants will have the right to quit from 
the trial at any time. Participants’ data will be 
strictly confidential. Questionnaires are filled out 
anonymously and are specified by an ID number. All 
the expenses are provided from the study budget. 
The study is approved at ethics committee of 
University of Social Welfare and Rehabilitation 
Sciences and is fully compliant with the Helsinki 




Providing skill training for people with 
schizophrenia in Iran is an urgent mental healthcare 
priority. The SISLST randomized controlled trial 
builds on previous observational evidence of the 
feasibility, acceptability and effectiveness of skill 
training programs. This trial is designed to provide 
evidence about the clinical effectiveness of the 
social and independent and social living skills 
training. Based on the participants and the diversity 
of the centers, we believe that the results of the study 
can be generalized beyond the study population. If 
the results confirm the hypotheses, this can have a 
significant impact on mental health policy and 
function of practitioners related to the scaling up 
psychosocial services for people with schizophrenia 
in Iran. This paper presents a protocol for an RCT of 
living skills training delivered to participants with 
schizophrenic participants in hospital or at outpatient 
centers. Also, the trial tries to understand participants' 
satisfaction of receiving this type of intervention. This 
study will be conducted according to the good clinical 
practice guidelines recommended for conducting 
multi center RCT. 
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